カタログ製品コード : C-EK11972

Human VEGF R3/Flt-4 ELISA kit

*写真はイメージです
24T ¥55,200 (¥2,300/T) (税別)
48T ¥69,200 (¥1,442/T) (税別)
96T ¥78,000 (¥813/T) (税別)
標準納期 : 2週間
メーカー名 遺伝子名 種交差性 測定範囲 サンプル量 適用サンプル ドキュメント
MultiSciences VEGF R3/Flt-4 Human 312.50 - 20000 pg/ml 100μl 血清、血漿、細胞培養上清

保存方法 :

キットは未開封の場合、4℃で保管すること。 開封後は標準溶液を-20℃で保存し、他の試薬は4℃で保存すること。

構成内容 :

96-well polystyrene microplate coated with a monoclonal antibody against VEGF R3
Human VEGF R3 Standard, lyophilized
VEGF R3 Detect Antibody
Assay Buffer (10×)
Substrate (TMB)
Stop Solution
Washing Buffer (20×)
Plate Covers

キーワード :

Homo sapiens,Human,Vascular endothelial growth factor receptor 3,VEGFR-3,Fms-like tyrosine kinase 4,FLT-4,Tyrosine-protein kinase receptor FLT4,FLT4,2.7.10.1,VEGFR3

ターゲット情報 :

This assay employs the quantitative sandwich enzyme immunoassay technique for the quantitative detection of human VEGF R3. The Human VEGF R3/Flt-4 ELISA is for research use only. Not for diagnostic or therapeutic procedures.
Vascular endothelial growth factor receptor 3 (VEGF R3), also known as Flt-4, is a tyrosine kinase receptor for VEGF-C and VEGF-D. The protein is thought to be involved in lymphangiogenesis and maintenance of the lymphatic endothelium. In lymphoma patients, high expression of VEGF R3 can been found in lymph endothelial cells isolated from the tumor tissue.
Mutations in this gene cause hereditary lymphedema type IA. Several studies have shown positive correlations between VEGF-C, VEGF-D and VEGF R3 expression and vascular invasion, lymphatic vessel and lymph node involvement. The VEGF-C/VEGF-D/VEGFR3 signaling pathway may provide a target for antilymphangiogenic therapy in prostate cancer, breast cancer, gastric cancer, lung cancer, non-small cell lung cancer, and so on.